SARC-F is a practical screening tool for sarcopenia risk but may not adequately reflect muscle quality. These findings suggest that incorporating muscle quality assessments (e.g. shear-wave elastography) into sarcopenia screening may improve diagnostic accuracy and clinical management.
Akin et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: